Science Corporation's brain tech is worth $3.5 billion after new funding
Science Corp raised a $400 million Series D to scale up its anti-blindness business.

TL;DR
- Science Corporation raised $400 million in a Series D funding round, valuing the company at $3.5 billion.
- The startup was founded in 2021 by former Neuralink president Max Hodak.
- Their first product, PRIMA, is a wearable and implantable chip designed to restore vision for those with age-related macular degeneration.
- PRIMA is approved in Europe and is currently being trialled for Stargardt's disease.
- The company aims to bring PRIMA to the U.S. via the FDA's Humanitarian Device Exemption.
- Science Corporation's long-term goal is to connect directly to the human brain with a bio-hybrid sensor.
- Initial human trials for brain-related conditions are being designed with Yale neurosurgery professor Murat Günel.